- Filed
- Dec 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Dec 16, 2025 | 590.15M sh |
| Shares Diluted | Q3 2025 · Nov 30, 2025 | 596.3M sh |
| Shares Diluted | Q3 2025 · Nov 30, 2025 | 598.05M sh |
| Shares Diluted | Q3 2025 · Nov 30, 2024 | 593.53M sh |
| Shares Diluted | Q3 2025 · Nov 30, 2024 | 590.54M sh |
| Stock Repurchased | Q3 2025 · Nov 30, 2025 | $4M |
| Stock Repurchased | Q3 2025 · Nov 30, 2025 | $34M |
| Stock Repurchased | Q3 2025 · Nov 30, 2024 | $0 |
| Capex | Q3 2025 · Nov 30, 2025 | $2.6M |
| Capex restated | Q3 2025 · Nov 30, 2024 | $2.7M |
| Operating Cash Flow | Q3 2025 · Nov 30, 2025 | $4.2M |
| Operating Cash Flow restated | Q3 2025 · Nov 30, 2024 | −$25.1M |
| Long Term Debt | Q3 2025 · Nov 30, 2025 | $196.2M |
| Long Term Debt | Q3 2025 · Feb 28, 2025 | $195.3M |
| Short Term Investments | Q3 2025 · Nov 30, 2025 | $33.9M |
| Short Term Investments | Q3 2025 · Feb 28, 2025 | $71.1M |
| Cash And Equivalents | Q3 2025 · Nov 30, 2025 | $270.3M |
| Cash And Equivalents | Q3 2025 · Feb 28, 2025 | $266.7M |
| Stockholders Equity | Q3 2025 · Nov 30, 2025 | $741.1M |
| Stockholders Equity | Q3 2025 · Aug 31, 2025 | $725.1M |
| Stockholders Equity | Q3 2025 · Feb 28, 2025 | $719.9M |
| Stockholders Equity restated | Q3 2025 · Nov 30, 2024 | $725.2M |
| Stockholders Equity restated | Q3 2025 · Aug 31, 2024 | $732.1M |
| Stockholders Equity restated | Q3 2025 · Feb 29, 2024 | $775.1M |
| Current Liabilities | Q3 2025 · Nov 30, 2025 | $253.3M |
| Current Liabilities | Q3 2025 · Feb 28, 2025 | $344.3M |
| Total Liabilities | Q3 2025 · Nov 30, 2025 | $477.3M |
| Total Liabilities | Q3 2025 · Feb 28, 2025 | $575.7M |
| Current Assets | Q3 2025 · Nov 30, 2025 | $543.2M |
| Current Assets | Q3 2025 · Feb 28, 2025 | $591.5M |
| Total Assets | Q3 2025 · Nov 30, 2025 | $1.22B |
| Total Assets | Q3 2025 · Feb 28, 2025 | $1.3B |
| Eps Diluted | Q3 2025 · Nov 30, 2025 | $0.02 |
| Eps Diluted | Q3 2025 · Nov 30, 2025 | $0.05 |
| Eps Diluted | Q3 2025 · Nov 30, 2024 | −$0.02 |
| Eps Diluted | Q3 2025 · Nov 30, 2024 | −$0.12 |
| Eps Basic | Q3 2025 · Nov 30, 2025 | $0.02 |
| Eps Basic | Q3 2025 · Nov 30, 2025 | $0.05 |
| Eps Basic | Q3 2025 · Nov 30, 2024 | −$0.02 |
| Eps Basic | Q3 2025 · Nov 30, 2024 | −$0.12 |
| Rd Expense | Q3 2025 · Nov 30, 2025 | $29.6M |
| Rd Expense | Q3 2025 · Nov 30, 2025 | $80.2M |
| Rd Expense restated | Q3 2025 · Nov 30, 2024 | $27.9M |
| Rd Expense restated | Q3 2025 · Nov 30, 2024 | $85.6M |
| Net Income | Q3 2025 · Nov 30, 2025 | $13.7M |
| Net Income | Q3 2025 · Nov 30, 2025 | $28.9M |
| Net Income restated | Q3 2025 · Nov 30, 2024 | −$10.5M |
| Net Income restated | Q3 2025 · Nov 30, 2024 | −$71.6M |
| Operating Income | Q3 2025 · Nov 30, 2025 | $11.9M |
| Operating Income | Q3 2025 · Nov 30, 2025 | $25.4M |
| Operating Income restated | Q3 2025 · Nov 30, 2024 | $19.5M |
| Operating Income restated | Q3 2025 · Nov 30, 2024 | $8.8M |
| Gross Profit | Q3 2025 · Nov 30, 2025 | $109.9M |
| Gross Profit | Q3 2025 · Nov 30, 2025 | $296.8M |
| Gross Profit restated | Q3 2025 · Nov 30, 2024 | $112.2M |
| Gross Profit restated | Q3 2025 · Nov 30, 2024 | $290.8M |
| Cost Of Revenue | Q3 2025 · Nov 30, 2025 | $31.9M |
| Cost Of Revenue | Q3 2025 · Nov 30, 2025 | $96.3M |
| Cost Of Revenue restated | Q3 2025 · Nov 30, 2024 | $31.4M |
| Cost Of Revenue restated | Q3 2025 · Nov 30, 2024 | $102.4M |
| Revenue | Q3 2025 · Nov 30, 2025 | $141.8M |
| Revenue | Q3 2025 · Nov 30, 2025 | $393.1M |
| Revenue restated | Q3 2025 · Nov 30, 2024 | $143.6M |
| Revenue restated | Q3 2025 · Nov 30, 2024 | $393.2M |